Q1 2023 Holdings
Filed 2023-05-09 | 71 holdings | $496.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Elevance Health Inc(ELV) | COM | 036752103 | $23.5M | 51,000 | 4.7% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $21.1M | 600,000 | 4.3% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $18.7M | 80,000 | 3.8% |
| Cooper COS Inc | COM NEW | 216648402 | $14.9M | 40,000 | 3.0% |
| Stryker Corporation(SYK) | COM | 863667101 | $14.3M | 50,000 | 2.9% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $12.9M | 81,000 | 2.6% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $12.7M | 770,000 | 2.6% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $12.1M | 727,100 | 2.4% |
| HCA Healthcare Inc(HCA) | COM | 40412C101 | $11.9M | 45,000 | 2.4% |
| Teleflex Incorporated(TFX) | COM | 879369106 | $11.7M | 46,000 | 2.3% |
| Cardinal Health Inc(CAH) | COM | 14149Y108 | $11.5M | 152,000 | 2.3% |
| Perkinelmer Inc(RVTY) | COM | 714046109 | $11.3M | 85,000 | 2.3% |
| Biogen Inc(BIIB) | COM | 09062X103 | $11.1M | 40,000 | 2.2% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $11.0M | 162,000 | 2.2% |
| Sarepta Therapeutics IncPut | PUT | 803607950 | $10.3M | 75,000 | 2.1% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $10.3M | 600,000 | 2.1% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $10.3M | 245,000 | 2.1% |
| Uniqure NV(QURE) | SHS | N90064101 | $10.1M | 500,000 | 2.0% |
| Idexx Labs Inc(IDXX) | COM | 45168D104 | $10.0M | 20,000 | 2.0% |
| Penumbra Inc(PEN) | COM | 70975L107 | $9.8M | 35,000 | 2.0% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $9.7M | 100,000 | 2.0% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $9.7M | 290,000 | 2.0% |
| Humana Inc(HUM) | COM | 444859102 | $9.7M | 20,000 | 2.0% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $9.6M | 90,000 | 1.9% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $8.6M | 178,000 | 1.7% |
| Guardant Health Inc(GH) | COM | 40131M109 | $8.2M | 350,000 | 1.7% |
| Baxter Intl Inc(BAX) | COM | 071813109 | $8.1M | 200,000 | 1.6% |
| Revance Therapeutics Inc(RVNCEUR) | COM | 761330109 | $8.1M | 250,000 | 1.6% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $7.6M | 152,000 | 1.5% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $7.5M | 345,000 | 1.5% |
| Align Technology Inc(ALGN) | COM | 016255101 | $7.4M | 22,000 | 1.5% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $7.0M | 395,000 | 1.4% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $6.8M | 85,000 | 1.4% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $6.5M | 71,000 | 1.3% |
| Envista Holdings Corporation(NVST) | COM | 29415F104 | $6.2M | 152,000 | 1.3% |
| Inari MED Inc(NARIUSD) | COM | 45332Y109 | $6.2M | 100,000 | 1.2% |
| Hologic Inc(HOLX) | COM | 436440101 | $6.1M | 75,000 | 1.2% |
| Moderna Inc(MRNA) | COM | 60770K107 | $5.4M | 35,000 | 1.1% |
| Lifestance Health Group Inc(LFST) | COM | 53228F101 | $5.3M | 709,000 | 1.1% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $5.0M | 179,000 | 1.0% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $4.9M | 213,000 | 1.0% |
| Laboratory Corp Amer Hldgs | COM NEW | 50540R409 | $4.6M | 20,000 | 0.9% |
| Supernus Pharmaceuticals Inc(SUPN) | COM | 868459108 | $4.5M | 125,000 | 0.9% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $4.5M | 100,000 | 0.9% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $4.5M | 12,000 | 0.9% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $4.4M | 61,000 | 0.9% |
| Surgery Partners Inc(SGRY) | COM | 86881A100 | $4.2M | 122,000 | 0.8% |
| Natera Inc(NTRA) | COM | 632307104 | $4.2M | 75,000 | 0.8% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $4.0M | 20,000 | 0.8% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $3.7M | 30,000 | 0.7% |